The report on rheumatology therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global rheumatology therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global rheumatology therapeutics market over the period of 2016 - 2024. Further, the author's Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.
The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include:
- Company reports and publications
- Government/institutional publications
- Trade and associations’ journals
- Databases such as WTO, OECD, World Bank, and among others.
- Websites and publications by research agencies
The global rheumatology therapeutics market ïs segmented on the basis of drug class, disease indication, and distribution channel
Global Rheumatology Therapeutics Market by Drug Class
- Disease Modifying Anti-rheumatic Drugs
- Nonsteroidal Anti-inflammatory Drugs
- Uric Acid Drugs
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- North America
- Takeda Pharmaceutical
- Genentech, Inc.
- Novartis AG
- Janssen Biotech, Inc.
- Amgen, Inc.
- AbbVie, Inc.
- Pfizer, Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc
1. Comprehensive analysis of global as well as regional markets of rheumatology therapeutics market.
2. Complete coverage of all the segments in rheumatology therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global rheumatology therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Rheumatology Therapeutics Market Overview
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Global Rheumatology Therapeutics Market
4. Global Rheumatology Therapeutics Market by Drug Class 2018 - 2024
4.1 Disease Modifying Anti-rheumatic Drugs
4.2 Nonsteroidal Anti-inflammatory Drugs
4.4 Uric Acid Drugs
5. Global Rheumatology Therapeutics Market by Disease Indication 2018 - 2024
5.1 Rheumatoid Arthritis
5.4 Psoriatic Arthritis
5.5 Ankylosing Spondylitis
6. Global Rheumatology Therapeutics Market by Distribution Channel 2018 - 2024
6.1 Hospital Pharmacy
6.2 Retail Pharmacy
6.3 Online Pharmacy
7. Global Rheumatology Therapeutics Market by Regions 2018 - 2024
7.1 North America
7.1.1 North America Rheumatology Therapeutics Market by Drug Class
7.1.2 North America Rheumatology Therapeutics Market by Disease Indication
7.1.3 North America Rheumatology Therapeutics Market by Distribution Channel
7.1.4 North America Rheumatology Therapeutics Market by Country
7.2.1 Europe Rheumatology Therapeutics Market by Drug Class
7.2.2 Europe Rheumatology Therapeutics Market by Disease Indication
7.2.3 Europe Rheumatology Therapeutics Market by Distribution Channel
7.2.4 Europe Rheumatology Therapeutics Market by Country
7.3.1 Asia-Pacific Rheumatology Therapeutics Market by Drug Class
7.3.2 Asia-Pacific Rheumatology Therapeutics Market by Disease Indication
7.3.3 Asia-Pacific Rheumatology Therapeutics Market by Distribution Channel
7.3.4 Asia-Pacific Rheumatology Therapeutics Market by Country
7.4.1 RoW Rheumatology Therapeutics Market by Drug Class
7.4.2 RoW Rheumatology Therapeutics Market by Disease Indication
7.4.3 RoW Rheumatology Therapeutics Market by Distribution Channel
7.4.4 RoW Rheumatology Therapeutics Market by Sub-region
8. Companies Covered
8.1 Takeda Pharmaceutical
8.3 Genentech, Inc.
8.4 Novartis AG
8.5 Janssen Biotech, Inc.
8.6 Amgen, Inc.
8.7 AbbVie, Inc.
8.8 Pfizer, Inc.
8.9 Bristol-Myers Squibb Company
8.10 Merck & Co., Inc